The incidence of inflammatory bowel disease (IBD) has risen significantly in recent decades, and some racial and ethnic minority groups have borne the brunt of that increase. Between 1970 and 2010, ...
Immunai collected a hefty $215 million series B round back in 2021 after raising $60 million through a series A earlier that same year. Those funds have helped the company stretch its reach from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback